相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。No association of atherosclerosis with digital ulcers in Japanese patients with systemic sclerosis: Evaluation of carotid intima-media thickness and plaque characteristics
Sei-ichiro Motegi et al.
JOURNAL OF DERMATOLOGY (2014)
Perturbations of Circulating Levels of RANKL-Osteoprotegerin Axis in Relation to Lipids and Progression of Atherosclerosis in HIV-Infected and -Uninfected Adults: ACTG NWCS 332/A5078 Study
Theodoros Kelesidis et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
The role of cytokines in inflammatory bone loss
Pedro P. C. Souza et al.
IMMUNOLOGICAL INVESTIGATIONS (2013)
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis
Piet Geusens
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
Atherosclerosis in Systemic Sclerosis A Systematic Review and Meta-Analysis
Karen Au et al.
ARTHRITIS AND RHEUMATISM (2011)
Vascular aging: From molecular mechanism to clinical significance
Motoji Sawabe
GERIATRICS & GERONTOLOGY INTERNATIONAL (2010)
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Shreenidhi M. Venuraju et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease
Unni M. Breland et al.
RHEUMATOLOGY (2010)
Subclinical atherosclerosis in scleroderma patients
N. Tsifetaki et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)
Osteoprotegerin, vascular calcification and atherosclerosis
Ann Van Campenhout et al.
ATHEROSCLEROSIS (2009)
Atherosclerosis in autoimmune diseases
Eiji Matsuura et al.
Current Rheumatology Reports (2009)
The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review
Mads Nybo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Endothelin-1 Does Not Change the Function of Monocyte-Derived Dendritic Cells Grown from Patients with Systemic Sclerosis
Gleb Slobodin et al.
IMMUNOLOGICAL INVESTIGATIONS (2008)
Circulating Osteoprotegerin and Soluble RANK Ligand in Systemic Sclerosis
Andrea Dovio et al.
JOURNAL OF RHEUMATOLOGY (2008)
The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications
Damaris Vega et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease
Stefan Kiechl et al.
CIRCULATION (2007)
RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis
A. R. Pettit et al.
RHEUMATOLOGY (2006)
Systemic sclerosis: hypothesis-driven treatment strategies
Christina Charles et al.
LANCET (2006)
Pathogenesis of atherosclerosis
E Falk
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Accelerated atherosclerosis in autoimmune rheumatic diseases
Y Shoenfeld et al.
CIRCULATION (2005)
Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis
SA Jimenez et al.
ANNALS OF INTERNAL MEDICINE (2004)
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in Monckeberg's sclerosis and atherosclerosis
M Schoppet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis
J Golledge et al.
STROKE (2004)
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby
CIRCULATION RESEARCH (2004)
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus
A Doria et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Carotid and femoral arterial wall mechanics in scleroderma
KS Cheng et al.
RHEUMATOLOGY (2003)
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
MD Mayes et al.
ARTHRITIS AND RHEUMATISM (2003)
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques
CR Dhore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
LC Hofbauer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study
DP Kiel et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
Macrovascular disease and systemic sclerosis
ML Ho et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)